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Mitochondrial DNA depleted (ρ0) human skin fibroblasts (HSF) with suppressed oxidative
phosphorylation were characterized by significant changes in the expression of 2100 nuclear
genes, encoding numerous protein classes, in NF-κB and STAT3 signaling pathways, and by
decreased activity of mitochondrial death pathway, compared to the parental ρ+ HSF. In contrast,
the extrinsic TRAIL/TRAIL-Receptor mediated death pathway remained highly active, and
exogenous TRAIL in a combination with cycloheximide (CHX) induced higher levels of
apoptosis in ρ0 cells compared to ρ+ HSF. Global gene expression analysis using microarray and
qRT-PCR demonstrated that mRNA expression levels of many growth factors and their adaptor
proteins (FGF13, HGF, IGFBP4, IGFBP6, and IGFL2), cytokines (IL6, ΙL17Β, ΙL18, ΙL19, and ΙL28Β) and
cytokine receptors (IL1R1, IL21R, and IL31RA) were substantially decreased after mitochondrial
DNA depletion. Some of these genes were targets of NF-κB and STAT3, and their protein products
could regulate the STAT3 signaling pathway. Alpha-irradiation further induced expression of
several NF-κB/STAT3 target genes, including IL1A, IL1B, IL6, PTGS2/COX2 andMMP12, in ρ+HSF, but
this response was substantially decreased in ρ0 HSF. Suppression of the IKK–NF-κB pathway by the
small molecular inhibitor BMS-345541 and of the JAK2–STAT3 pathway by AG490 dramatically
increased TRAIL-induced apoptosis in the control and irradiated ρ+ HSF. Inhibitory antibodies
against IL6, the main activator of JAK2–STAT3 pathway, added into the cell media, also increased








E X P E R I M E N T A L C E L L R E S E A R C H 3 1 7 ( 2 0 1 1 ) 1 5 4 8 – 1 5 6 6
⁎ Corresponding author. Fax: +1 212 305 3229.
E-mail address: vni3@columbia.edu (V.N. Ivanov).
Abbreviations: ATM, Ataxia Telangiectasia Mutated protein kinase; CHX, cycloheximide; COX-2, cyclooxygenase-2; DR4, death receptor-4; DR5,
death receptor-5; EMSA, electrophoretic mobility shift assay; ERK, extracellular signal-regulated kinase; FACS, fluorescence-activated cell sorter;
IETD, N-acetyl-Ile-Glu-Thr-Asp-CHO (aldehyde); IL1β, interleukin1β; IL6, interleukin-6; IL8, interleukin-8; IκB, inhibitor of NF-κB; IKK, inhibitor
nuclear factor kappa B kinase; LEHD, N-acetyl-Leu-Glu-His-Asp-CHO (aldehyde); MAPK, mitogen-activated protein kinase; MFI, medium
fluorescence intensity; NF-κB, nuclear factor kappa B; PI, propidium iodide; PI3K, phosphoinositide 3-kinase; PTGS2, prostaglandin-endoperoxide
synthase 2; ROS, reactive oxygen species; TNFα, tumor necrosis factor alpha; TRAIL, TNF-related apoptosis inducing ligand; TRAIL-R, TRAIL-
Receptor; XIAP, X-linked inhibitor of apoptosis
1 Equal contribution.
0014-4827/$ – see front matter © 2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.yexcr.2011.03.012
ava i l ab l e a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ loca te /yexc r
Author's personal copy
indicated that NF-κB activation was partially lost in ρ0 HSF resulting in downregulation of the basal
or radiation-induced expression of numerous NF-κB targets, further suppressing IL6–JAK2–STAT3
that in concert with NF-κB regulated protection against TRAIL-induced apoptosis.
© 2011 Elsevier Inc. All rights reserved.
Introduction
The discovery of tumor necrosis factor-related apoptosis inducing
ligand (TRAIL) and its receptors TRAIL-R1 (DR4/TNFRSF10A) and
TRAIL-R2 (DR5/TNFRSF10B) provided an additional opportunity
for cancer treatment, because TRAIL-Receptors demonstrated
substantially higher levels of surface expression on many types
of cancer cells compared to normal cells [1,2]. This was somewhat
opposite to the distribution of Fas-Receptor and TNF-Receptors,
both of which exhibit varying surface expression in normal and
cancer cells. However, extensive investigation of TRAIL sensitivity
among cancer cell lines indicated that almost 50% of these lines
were resistant to TRAIL-induced death [3]. Numerous studies were
performed on combined treatment of cancer cells to overcome
their resistance to TRAIL. Different chemotherapeutic drugs,
ionizing radiation, arsenic and small molecular inhibitors of
signaling pathways used in a combination with TRAIL (or TRAIL-
Receptor agonistic monoclonal antibodies) demonstrated different
degrees of induction of TRAIL-induced apoptosis with promising
perspectives for the clinic [4–6].
The existence of two death signaling pathways in cells, the
“extrinsic” death-receptor-mediated and the “intrinsic”mitochon-
drial pathways highlighted the role of mitochondria in the
regulation of programmed cell death [7,8]. Co-existence and
cross-talk between these pathways in normal cells and in early-
phase cancer cells was often followed by suppression of the
mitochondrial pathway in late-phase cancer cells, due to a general
inhibition of mitochondrial function [9,10] and a strong upregula-
tion of gene expression of anti-apoptotic proteins of the Bcl2
family during cancer development [11–13].
Is there a role for the TRAIL/TRAIL-R-mediated death pathway
in cells with suppressed mitochondrial functions, including
malignant tumor cells? To address this question, we used a well-
established model of ρ0 cells, which lack mitochondrial (mt) DNA
as a result of prolonged treatment of the parental (ρ+) cells with
low concentrations of ethidium bromide [14]. Two experimental
models of ρ0 cells were used in our study: human skin fibroblasts
(HSF) immortalized by SV40 T-antigen and human small airway
epithelial cells (SAEC) immortalized by the catalytic subunit of
human telomerase (hTERT). Previous studies using similar cell
systems of ρ0 cells and the parental ρ+ cells demonstrated
increased levels of some types of apoptosis in mtDNA-depleted
cells in culture conditions [15] and in vivo [16], while the cytotoxic
and gene-inducing effects of TNF were abrogated in these cells
[17]. Even though cytochrome-c release could occur from defective
mitochondria [18], there is evidence that ρ0 cells exhibited an
increased resistance to the mitochondrial apoptotic pathway [19–
21]. The aim of the present study was to investigate TRAIL-induced
apoptosis in the context of global changes of nuclear gene
expression induced by dysfunction of mitochondria in ρ0 cells,
with special attention to NF-κB- and STAT3-driven gene expres-




Human Killer-TRAIL and human Fas Ligand (FasL) were purchased
from Axxora (San Diego, CA, USA). PI3K inhibitor LY294002, IKK
inhibitor BMS-345541 and JAK2 inhibitor AG490 were purchased
from Calbiochem/EMD Chemicals (San Diego, CA, USA).
Cell culture
Human skin fibroblasts (HSF) immortalized by SV40 T antigen [22]
were maintained in a 4.5 g/l glucose DMEMwith 4 mM L-glutamine
and 100 mg/l sodium pyruvate supplemented with 10% fetal bovine
serum, 100 IU/ml penicillin, and 100 μg/ml streptomycin. Human
small airway epithelial cells immortalized by hTERTwere previously
established in our lab. Cells were cultured in SAGM medium.
Mitochondrial (mt) DNA depleted ρ0 cells were established from the
corresponding parent ρ+ cells (HSF and SAEC) using prolonged
exposure to ethidium bromide (50 ng/ml) in growth medium
supplementedwith50 μg/mluridine [23]. These established cultures
of ρ0 cells were further maintained in growth medium supplemen-
ted with 50 μg/ml uridine.
Irradiation procedure and survival analysis
Exponentially growing human skin fibroblasts (HSF) were plated
in the concentric strip mylar dishes two days before irradiation to
ensure a confluent state. A 50 cGy dose of 4He ions (120 keV/μm)
was delivered to the cells using the track segment irradiation
feature of the 5.5-MV Singletron accelerator at the Radiological
Research Accelerator Facility of Columbia University. After irradi-
ation at selected time points, cells were harvested and used for
endpoint analysis. Non-irradiated, mock-treated control cells and
α-irradiated cells were collected 24 h after irradiation. Cultures
were trypsinized, cell numbers were determined with a Coulter
counter, and aliquots of the cells were reseeded into 100-mm-
diameter dishes for colony formation. Cultures for clonogenic
survival assays were incubated for 12 days, at which time they
were fixed with formaldehyde and stained with Giemsa. The
numbers of colonies were counted to determine the surviving
fraction as described [24].
Detection of mitochondrial (mt) DNA
Mitochondrial (mt) DNA was detected in human fibroblasts using
PCR with a set of primers, 5′-CCCAAACCCACTCCACCTTACTACC-3′
(sense) and 5′-AGCTGTTCTTAGGTAGCTCGTCTGG-3′ (antisense),
designed to produce a 251 bpmtDNA fragment. PCR amplifications
were performed for 30 cycles using a DNA thermal cycler model
9700 (Perkin-Elmer). Each PCR cycle consisted of denaturation at
95 °C for 30 s, annealing at 55 °C for 30 s and extension at 72 °C for
30 s. After the last cycle, the sampleswere incubated at 72 °C for an
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additional 10 min, separated by electrophoresis in 1% agarose gels,
and stained with ethidium bromide.
RNA isolation and gene expression studies using microarray
RNA isolation was performed in parallel across irradiated and non-
irradiated samples. After treatment, cellswere lysed at 30 min, 1 h, 4 h
and 24 h time points. All experiments were done in triplicate. We
analyzed the 4-h RNA by microarray hybridization. Cyanine-3 (Cy3)
labeled cRNAwas prepared from 0.3 μg RNA using the One-Color Low
RNA Input Linear Amplification PLUS kit (Agilent). Dye incorporation
and cRNA yield were monitored with the NanoDrop ND-1000
Spectrophotometer (Thermo Scientific). 1.5 μg of cRNA (>9 pmol
Cy3 per μg cRNA) was fragmented, hybridized to Agilent Whole
Human Genome Oligo Microarrays (G4112F) using the Gene
Expression Hybridization Kit, and washed following Agilent's recom-
mendations. Slides were scanned with the Agilent DNA Microarray
Scanner (G2505B). Default parameters of Feature Extraction Software
9.1 (Agilent) and grid version 014850_D_F_20090416 were used for
image analysis, data extraction, background correction, and flagging of
non-uniform features.
Background corrected intensities were log2 transformed and
median-normalized in BRB-Array Tools, Version 3.8.0. Non-
uniform outliers or features not significantly above background
intensity in 40% or more of the hybridizations were filtered out,
leaving 40,472 features. A further filter requiring a minimum 1.5-
fold change in at least 20% of the hybridizations was then applied
yielding a final set of 9066 features that were used for subsequent
analyses. The microarray data are available through the Gene
Expression Omnibus database using accession number GSE24945.
BRB-Array Tools was used to identify genes that were
differentially expressed between sham control and irradiated
cells using a random-variance paired t-test, an improvement over
the standard t-test that permits sharing information among genes
about within-class variation without assuming that all genes have
the same variance [25]. The test compares the differences in mean
log-intensities between classes relative to the expected variation
in mean differences computed from the independent samples.
Genes with p-values less than 0.005 were considered statistically
significant. The false discovery rate (FDR) was also estimated for
each gene using the method of Benjamini and Hochberg [26], to
control for false positives.
Quantitative real-time PCR (qRT-PCR)
The High-Capacity cDNA Archive Kit (Life Technologies, Foster City,
CA) was used to prepare cDNA from total RNA. A custom low-density
TaqMan array (Life Technologies, Foster City, CA) was designed using
validatedassaysandwaspreviouslydescribed [27].Genes for inclusion
on the low-density array (LDA) were selected on the basis of
differential expression and low FDR, and seven previously selected
endogenous control genes [27]were also included. For gene validation
studies, 100 ng cDNA was used as input for LDAs. Quantitative real
time PCR reactions were performed with the ABI 7900 Real Time PCR
System using Universal PCR Master Mix (Life Technologies), with
initial activation at 50 °C for 120 s and 94.5 °C for 10 min followed by
40 cycles of 97 °C for 30 s and 59.7 °C for 60 s. Relative fold-inductions
were calculatedby theΔΔCTmethodaspreviouslyused [27] using SDS
version 2.3 software (Life Technologies). We applied geNorm [28] to
the seven endogenous control genes on the LDAs to determine the
most appropriate genes for normalizing the results. The LDA data was
normalized to ubiquitin C (UBC) gene expression levels.
Gene ontology analysis
The genes responding significantly (p<0.005) to both treatments:
mitochondrial depletion or irradiation were imported into
PANTHER [29] and the number of genes in each functional
classification category was compared against the number of
genes from the NCBI human genome in that category. The binomial
test was used to statistically determine over- or under-represen-
tation of PANTHER classification.
Transfection and luciferase assay
The NF-κB luciferase reporter containing two κB binding sites, and
STAT-Luc reporter containing three repeats of GAS sites from the
Ly6A/E promoter were used to determine NF-κB and STAT
transactivation, respectively. Transient transfection of different
reporter constructs (1 μg) together with pCMV-β-Galactosidase
(0.25 μg) into 5×105 cells was performed using Lipofectamine
(Life Technologies-Invitrogen). Proteins were prepared for β-Gal
and luciferase analysis 16 h after transfection. Luciferase activity
was determined using the Luciferase assay system (Promega,
Madison, WI) andwas normalized based on β-galactosidase levels.
FACS analysis of receptor surface levels
Surface levels of TRAIL-R1/DR4 and TRAIL-R2/DR5 were deter-
mined by staining with the PE-labeled mAbs from eBioscience
(San Diego, CA, USA). Surface levels of FAS, TNFR1, NGFR1 p75 and
IL6R were determined using the PE-labeled mAbs from BD
Pharmingen (San Jose, CA, USA). A FACS Calibur flow cytometer
(Becton Dickinson, Mountain View, CA, USA) combined with the
CellQuest program was used to perform flow cytometric analysis.
Apoptosis studies
Cells were exposed to soluble TRAIL (50 ng/ml) alone or in
combination with cycloheximide (2 μg/ml), with sodium arsenite
(5 μM). Additionally, different variants of combined treatment
were used, including α-irradiation (0.5 Gy) followed by TRAIL
treatment. Apoptosis was then assessed by quantifying the
percentage of hypodiploid nuclei using FACS analysis.
Immunofluorescence
Immunofluorescence was performed as described previously [30].
Cells were grown on glass coverslips in growth medium, fixed
(PBS, 4% paraformaldehyde for 10 min), permeabilized (PBS, 0.5%
Triton X-100 for 5 min) and stained with antibodies to pyruvate
dehydrogenase (Binding Site, United Kingdom). Secondary anti-
bodies were obtained from Jackson ImmunoResearch. Nuclear
staining was done with propidium iodide. Images were captured
using a laser confocal microscope (Nikon).
Western blot analysis
Total cell lysates (50 μg protein) were resolved on SDS-PAGE, and
processed according to standardprotocols. Themonoclonal antibodies
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used forWesternblotting included: anti-β-Actin (Sigma, St. Louis,MO,
USA); anti-FLIP (NF6) (Axxora); anti-phospho-p53 (Ser15); anti-
Smac/Diablo; anti-p21 Waf1/Cip1; anti-caspase-8, anti-caspase-3
(Cell Signaling); anti-XIAP (BD Biosciences); anti-COX2 (Cayman
Chemical). The polyclonal antibodies used included: anti-total p53;
anti-phospho-p44/p42 MAP kinase (Thr202/Tyr204) and anti-p44/
p42 MAP kinase; anti-phospho-AKT (Ser473) and anti-AKT; anti-
PARP; anti-BAX, anti-Bcl-xL (Cell Signaling); anti-Survivin (R&D). The
secondary antibodies were conjugated to horseradish peroxidase;
signals were detected using the ECL system (Thermo Scientific,
Rockford, IL, USA).
ELISA
Antibody pairs used in sandwich ELISA for this study were all
commercially available. Kits to detect IL6, TNFα and IL1β were
from Invitrogen.
Determination of cytochrome-c oxidase enzymatic activity
Biochemical assays for cytochrome-c oxidase activity were done as
described [20]. Briefly, cells in log phase of growth were collected
and re-suspended in 50 mM potassium phosphate (pH 7.0). Cells
were lysed by two cycles of freezing and thawing. Cell lysates were
treated with 1.3 mM lauryl maltoside before enzymatic measure-
ments. Cytochrome-c oxidase activity was assessed by measuring
the oxidation of reduced cytochrome c at 550 nm (nmol oxidized
cytochrome c per min per mg protein).
Determination of caspase-8, caspase-9 and caspase-3
enzymatic activities
Enzymatic activities of caspase-8, caspase-9 and caspase-3 in total
cell lysates prepared before and after apoptotic stimulation of HSF
was determined using R&D caspase colorimetric assay with IETD-
pNA, LEHD-pNA and DEVD-pNA substrates, respectively.
Oxygen consumption
Oxygen consumption in intact cells was assayed as described
previously [30]. Briefly, 1×107 cells were suspended in 1.5 ml of
DMEM lacking glucose, and oxygen concentration was assayed over
3 min at 37 °C in a Hansatech (MA) Clark's oxygen electrode unit.
Statistical analysis
Data from 3 to 4 independent experiments were calculated as means
and standard deviations. Comparisons of results between treated and
control groupsweremade by the Student's t-tests. A p-value of 0.05 or
less between groups was considered significant.
Results
Global gene expression in mtDNA-depleted human fibroblasts
Mitochondria play a crucial role in regulation of numerous cell
functions, including energy production, stress response and pro-
grammed cell death. To investigate mitochondria-dependent mech-
anisms controlling death receptor (TRAIL-R and FAS) mediated
apoptosis, in the present study we used mitochondrial (mt) DNA
depleted (ρ0) human skin fibroblasts (HSF) and their parental ρ+HSF.
HSF are known to produce pro-inflammatory cytokines in a NF-κB-
dependent manner and to facilitate tumor-promoting inflammation
[31]. Depletion of mtDNA in HSF after prolonged incubation with
ethidium bromide was detected by PCR with the corresponding
primers (Fig. 1A). The critical characteristic of ρ0 HSFwas the dramatic
suppression of general mitochondrial function, due to the absence of
mtDNA encoding rRNAs, tRNAs and 13 polypeptides, including three
cytochrome-c oxidase subunits [32]. It was accompanied by inhibition
of cytochrome-c oxidase enzymatic activity (Fig. 1B), inhibition of
oxidative phosphorylation and suppression of mitochondrial mem-
brane potential (Fig. 1C) linked with strong down-regulation of
oxygen consumption (Fig. 1D). At the morphological level, the
mitochondrion was present in ρ0 cells with decreased expression of
nuclear DNA-encoded mitochondrial proteins, such as pyruvate
dehydrogenase (Fig. 1C).
Comparison of ρ0 and normal fibroblast gene expression by
whole genome microarray profiling showed that mitochondrial
depletion significantly changed the gene expression levels of 2100
genes (with false discovery rate <0.04) (Fig. 2A and Suppl.
Table 1). Ontology analyses showed that changes in gene
expression were highly enriched in functions affected signaling
molecules (134 genes, p-value 10−10), extracellular matrix pro-
teins (60 genes, p-value 10−6), transcription factors (179 genes,
p-value 10−5) and a broad range of metabolic enzymes (Fig. 2B).
Of the 2100 genes, 53% were suppressed after mitochondrial
depletion and gene ontology showed that there was significant
enrichment in number of suppressed genes for the PANTHER
protein class of oxidoreductases (p-value 10−3), which includes
proteins involved in electron transport and oxidative phosphor-
ylation (Table 1 and Suppl. Table 1). Expression levels of the
master regulators of mitochondriogenesis, PPARGC1A (Peroxisome
proliferator-activated receptor gamma, coactivator 1) were dramat-
ically decreased in ρ0 fibroblasts (Table 1). Additionally, expres-
sion of many growth factors, growth factor adaptor proteins
(FGF13, HGF, IGFBP4, IGFBP6, and IGFL2), cytokines (IL6, ΙL17Β, ΙL18,
ΙL19, and ΙL28Β), cytokine receptors (IL1R1, IL21R, and IL31RA) and
downstream targets (IL1RAP2 and TNFAIP6) was substantially
decreased in ρ0 HSF versus normal HSF (Table 1).
Furthermore, a class of negatively regulated genes contained some
members of the tumor necrosis factor receptor superfamily,metabolic
enzymes of different subclasses (not only oxidoreductases, but also
urokinase, protein kinase C-theta and others) and many transcription
factors, including NF-ATc1 (Table 1 and Suppl. Table 1). A common
feature of several genes (IL6, IL17B, IL31RA, PTGES, TNFAIP6, S100A3,
and S100A4) with downregulated expression in ρ0 HSF was a role for
transcription factor NF-κB in the control of their expression (http://
people.bu.edu/gilmore/nf-kb/target/index.html). Furthermore, IL19,
IL24 and IL28 mRNA levels were also decreased in ρ0 HSF. The
corresponding cytokines (IL6, IL19, IL24 and IL28) could be involved in
autocrine/paracrine regulation of JAK2–STAT3 signaling pathway,
while active STAT3 is known to control numerous genes, including
COX2, EGFR1, several interleukin receptors, Cyclin A1 and Cyclin D3 and
general cell survival andproliferation [33,34]. Interestingly, severalNF-
κB-dependent genes (GADD45-alpha, IL8 and TNFAIP3) (http://people.
bu.edu/gilmore/nf-kb/target/index.html) demonstrated upregulated
levels of expression in mtDNA-depleted cells (Table 2 and Suppl.
Table 1). However, TNFAIP3 encoding proteinA20 is actually known as
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a suppressor of NF-κB activation, due to its de-ubiquitinating activity
[35]. Furthermore, genes with increased expression levels included
NFKBIE (NF-κB inhibitor-ε),NFKBIL1 (NF-κB inhibitor-like1) SOCS2, IL11,
EGFR1 and TLR3 and 4 (Toll-like Receptors 3 and 4), which might
regulate theNF-κBandSTAT3 signalingpathways inbothnegative and
positive directions. On the other hand, the upregulation of HIF1A,
GSTA2 and TF (Transferrin) gene expression in hypoxic conditions of
mtDNA-depleted cells was quite expected (Table 2). Importantly, HIF-
1 has been previously demonstrated as a critical transcriptional regu-
lator,which induced strong activationof glycolysis and suppressed the
Krebs cycle and mitochondrial respiration in cancer cells [36].
The family of genes encoding KRAB-zinc finger proteins was
also enriched in the 2100 genes that were changed in ρ0 cells.
KRAB-zinc finger proteins are transcriptional regulators, and we
found that mitochondrial depletion caused the up-regulation of
expression of 67 members of this family (Suppl. Table 1). Recently,
Zinc finger protein 10 (ZNF10), a member of this family, has been
shown to cause long-range repression of genes, which was
Fig. 1 –Mitochondrial (mt)DNA-depleted human skin fibroblasts (HSF ρ0) and their parental cells (HSF ρ+). A. PCR amplification of
the mtDNA fragment (251 bp) from HSF ρ+ using mtDNA primer set. B. Cytochrome-c oxidase activity (oxidized cytochrome-c,
nmol/min/mg protein) in total cell extracts from ρ+ and ρ0 cells was determined as described in “Methods”. C. Immunofluorescence
of mitochondrial pyruvate dehydrogenase (green) with PI-stained red nuclei in ρ+ and ρ0 cells. Mitochondrial membrane potential
was detected using JC-1 probe based on change of green to red fluorescence. D. Rates of oxygen consumption (femtomole/cell/min)
for ρ+ and ρ0 cells were determined using an oxygen electrode unit.
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associated with heterochromatin spreading [37]. We observed in
our study that ZNF10 gene expression was up-regulated 5-fold in
ρ0 cells (Table 2) that could have implication for the changes in
gene expression patterns. Taken together, our results demonstrat-
ed numerous changes in nuclear gene expression in mtDNA-
depleted cells versus normal fibroblasts with a potential role for
NF-κB- and STAT3-directed transcription among many other
transcriptional activators and repressors. Consequently, the
Fig. 2 – Differentially expressed genes inmtDNA-depleted human skin fibroblasts (HSF ρ0) comparedwith their parental cells (HSF ρ+).
A. Comparison of gene expression was performed using microarrays. The log transformed fold change in relative gene expression is
plotted on the x-axis and the log transformed p-value is plotted on the y-axis. Each point in the graph represents an individual gene.
Genes toward the top of the graph have a lower p-value and the genes further to the left and the right of the x-axis have greater fold
change between classes. From paired class comparison of HSF ρ0 and HSF ρ+ gene expression, there were 2100 genes that were
differentially expressed between the two conditions, FDR<0.04. B. Gene ontology analysis using PANTHER showing functional
enrichment of genes, number of genes in each protein class is indicated out of the 2100 differentially expressed genes. Categories are
ordered by significance (p-values).
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regulation of expression of individual genes in mtDNA-depleted
cells was dependent on cooperative effects of many signaling
pathways and the corresponding transcription factors with co-
stimulatory or co-inhibitory functions.
Radiation response and inducible NF-κB/STAT3-dependent
gene expression in mtDNA-depleted human skin fibroblasts
Ionizing radiation and chemotherapy are two predominant therapeu-
tic modalities for cancer treatment. Ionizing radiation is known to
coordinately activate expression of large number of individual genes
controlling numerous functions, including cell survival and cell death
[38,39]. We used α-particle irradiation (0.5 Gy) of normal and
mtDNA-depleted fibroblasts to further elucidate the regulatory role
of mitochondria in radiation response that might dramatically affect
cell proliferation and survival. We performed global analysis of gene
expression in ρ0 and ρ+ HSF 4 h after exposure to α-irradiation
(0.5 Gy) using microarrays and found that expression of 142 genes in
ρ+ HSF and 126 genes in ρ0 HSF responded to irradiation (p-
value<0.005) (Suppl. Tables 2 and 3). Interestingly, we found a few
genes that showed upregulation of expression in ρ+ and down-
regulation in ρ0 cells after irradiation; however, very few genes
showed the opposite pattern (top and bottom of the heatmap, Fig. 3A,
the left side).Geneontology analysis confirmed substantial differences
in the radiation response of ρ0 versus ρ+ HSF that affected
differentially critical biological processes and showed significant
enrichment in the number of genes, which regulate signaling and
communication processes in the ρ0 cells after irradiation, while
cellulardefenseprocesseswere implicated in thenormal cell radiation
response (Figs. 3A–C). Among these genes, several NF-κB targets
(IL31RA,MMP12, PTGS2/COX2) demonstrated substantially decreased
mRNA levels in ρ0 HSF compared to ρ+ HSF 4 h after irradiation
(Fig. 3C). The corresponding receptor proteins, products of IL31RA and
IL2RG genes, are known to participate in JAK–STAT3 activation;
consequently, suppression of these genes in ρ0 HSF after exposure to
radiation might cause serious disturbance of this pathway.
Using qRT-PCR for additional analysis and validation of radiation-
induced changes in gene expression in extended time frame 0.5–24 h
after treatment, we further observed that α-particle irradiation
increased expression levels of the numerous NF-κB transcriptional
targets in ρ+ HSF with different kinetics for individual genes.
Importantly, NF-κB-driven pro-inflammatory signature genes, IL1A,
IL1B, IL6, IL8, IL33, PTGS2/COX2,MMP1 andMMP3 exhibited substantial
upregulation of expression at time points between0.5 h and24 h after
irradiation that was partially suppressed in mtDNA-depleted cells
(Figs. 4A and B). Furthermore, a class of NF-κB target genes with
differential kinetics of expression after exposure to irradiation of ρ0
and ρ+ HSF included DNA repair/cell cycle regulator GADD45A,
superoxide dismutase (SOD2), cyclin-dependent kinase inhibitor 1A
(CDKN1A, p21-Cip1), as well as, CXCL2, CXCL3 and CXCL5 (Fig. 4A).
TNFR1(TNFRSF1)geneexpressionwasonlymarginally regulatedby α-
irradiation inHSF (Fig. 4B). Finally, expression of IL6 gene (Figs. 4A and
B) was followed by increased IL6 secretion into the cell media 48 h
after exposure of HSF to α-particles. This secretion was substantially







Cytochrome b5 reductase 2 (CYB5R2), mRNA CYB5R2 2966 0.14 7.44E−05
Cytochrome b–c1 complex subunit 3 (Complex III subunit 3) CYTB 8924 0.00081 6.00E−07
Fibroblast growth factor 13 (FGF13), transcript variant 1 FGF13 17893 0.1 1.58E−05
Hepatocyte growth factor (HGF), transcript variant 2 HGF 1587 0.19 0.0004288
Insulin-like growth factor binding protein 4 (IGFBP4) IGFBP4 40120 0.4 0.0025358
Insulin-like growth factor binding protein 6 (IGFBP6) IGFBP6 7912 0.29 0.0003373
IGF-like family member 2 (IGFL2), transcript variant 1 IGFL2 7158 0.29 0.0018106
Inhibitor of kappa B, kinase epsilon (IKBKE) IKBKE 16178 0.41 7.12E−05
Interleukin 17B (IL17B) IL17B 16507 0.29 0.0008358
Interleukin 18 (interferon-gamma-inducing factor) (IL18) IL18 914 0.048 0.0011637
Interleukin 19 (IL19), transcript variant 1 IL19 12452 0.19 0.001338
Interleukin 1 receptor, type I (IL1R1) IL1R1 31100 0.33 0.0006962
Interleukin 1 receptor accessory protein-like 2 (IL1RAPL2) IL1RAPL2 8613 0.28 0.004756
Interleukin 21 receptor (IL21R), transcript variant 2 IL21R 31421 0.043 2.46E−05
Interleukin 24 (IL24), transcript variant 1 IL24 21732 0.22 0.0001206
Interleukin 28B (IL28) (interferon, lambda 3) IL28B 25800 0.33 0.0023302
Interleukin 31 receptor A (IL31RA) IL31RA 33280 0.18 0.0009293
Interleukin 6 (interferon, beta 2) (IL6) IL6 9255 0.43 0.0040936
Mitogen-activated protein kinase kinase kinase 8 (MAP3K8) MAP3K8 8124 0.29 0.004285
Metallothionein 1M (MT1M) MT1M 29528 0.046 4.60E−05
Nuclear factor of activated T-cells, cytoplasmic 1 (NF-ATC1) NFATC1 22496 0.12 6.95E−05
Plasminogen activator, urokinase (PLAU) PLAU 1130 0.057 4.40E−05
Peroxisome proliferator-activated receptor gamma, coactivator 1 PPARGC1A 7742 0.17 0.0003335
Protein kinase C, theta (PRKCQ) PRKCQ 33583 0.32 0.0011877
Prostaglandin E synthase (PTGES) PTGES 33403 0.39 0.0007839
Ribosomal protein S6 kinase-like 1 (RPS6KL1) RPS6KL1 14792 0.25 0.0035587
Transforming growth factor, beta-induced, 68 kDa (TGFBI) TGFBI 22104 0.43 0.0049484
Tumor necrosis factor, alpha-induced protein 6 (TNFAIP6) TNFAIP6 31876 0.066 6.00E−06
Tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A) TNFRSF10A 15317 0.41 0.0011807
Tumor necrosis factor receptor superfamily, member 19 (TNFRSF19) TNFRSF19 28863 0.21 0.0010152
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downregulated in mtDNA-depleted HSF (Fig. 4C). Increased secretion
of IL1β (2-fold) after irradiationwas also observed for normal, but not
for mtDNA-depleted HSF (data not shown). Collectively, these results
indicated a special role for induction of NF-κB activity in the regulation
of the cellular radiation response and a connection between
mitochondrial function and NF-κB activation based on substantial
differences between expression of NF-κB target genes in ρ0 and ρ+
HSF.
Characterization of the main signaling pathways in normal
and mtDNA-depleted human fibroblasts following irradiation
A typical pattern of radiation-induced signaling pathways in HSF
includes: i) DNA-damage-induced activation of ATM followed by
ATM-dependent p53-Ser15 phosphorylation (Figs. 5A and B);
ii) activation of MAPK pathways (Fig. 5A); iii) a complex regulation
of NF-κB transacting activity (Fig. 5C) probably through both the
endogenous ATM-directed and the secondary ligand/receptor
routes (such as TNF/TNFR1, FASL/FAS, TRAIL/TRAIL-R1/R2, IL1β/
IL1R, IL33/ST2) with resulting differences between ρ+ and ρ0 cells;
iv) regulation of STAT3 transacting activity probably through both
ATM-directed and ligand/receptor roots (such as IL6/IL6R) resulting
in pronounced differences between ρ+ and ρ0 cells before and after
irradiation (Fig. 5D); and v) PI3K–AKT pathway (Figs. 5A and B).
ATM-dependentphosphorylationof p53onSer15 andactivationof
ERK1/2 by MEK-dependent Thr202/Tyr204 phosphorylation were
relatively similar in both ρ0 and ρ+ HSF following α-irradiation
(Fig. 5A). However, consistent with a partial suppression of p53
activity in these cell lines by SV40 T-antigen (used for immortalization
of fibroblasts), most of the downstream p53 responsive pathways
were not functional before or after irradiation [40]. A strong activation
of ERK1/2wasobserved inbothρ+andρ0 cells 4 hafter irradiationand
could be detected at decreased levels even 24 h after treatment
(Figs. 5A and B). On the other hand, levels of active phospho-AKT
(Ser473) demonstrated marginal differences between ρ+ and ρ0 cells
4 and 24 h after irradiation (Figs. 5A and B). NF-κB-dependent
luciferase reporter activity (reflecting a general NF-κB-dependent
transcriptional activity) increased substantially after α-irradiation in
ρ+ compared with ρ0 cells. TNFαwas used as the positive control for
NF-κB activation (Fig. 5C). Because the genes of the pro-inflammatory
signature could be regulated by NF-κB in concert with STAT3, we
further demonstrated using STAT3-dependent luciferase activity that
α-irradiation of HSF could upregulate STAT3-transacting activity via
differential regulation in ρ+ and ρ0 cells. IL6 was used as a positive
control for JAK2–STAT3 activation (Fig. 5D).
At protein level a consequence of α-particle irradiation (24 h
after exposure) was upregulation of the NF-κB/STAT3-dependent
PTGS2 (COX2), a critical pro-inflammatory enzyme that was
partially suppressed in ρ0 cells compared to ρ+ cells (Fig. 5B). On
the other hand, an additional increase in total DR5 levels was
relatively similar in ρ+ and ρ0 cells 24 h after irradiation (Fig. 5B). As
we previously observed [5], ionizing radiation up-regulated surface







Bcl2 transcript variant alpha BCL2 7248 2.44 0.0011768
BCL2-like 11 (apoptosis facilitator) (BCL2L11)/BIM, transcript variant 1 BCL2L11 29712 2.27 0.0040615
CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA) CEBPA 8875 4.94 0.0010589
CCAAT/enhancer binding protein (C/EBP), gamma (CEBPG) CEBPG 100 3.3 0.0003227
E2F transcription factor 3 (E2F3) E2F3 34560 2.43 0.0014849
Epidermal growth factor receptor, transcript 1 EGFR 7505 2.12 0.0030475
Fibroblast growth factor 12 (FGF12), transcript variant 2 FGF12 26299 3.43 0.0002985
GADD45-alpha GADD45A 33558 2.61 0.0031693
Glutathione S-transferase alpha 2 (GSTA2) GSTA2 26996 3.4 0.0008577
Hypoxia inducible factor 1, alpha subunit (HIF1A) HIF1A 2124 2.02 0.0037596
Harakiri, Bcl2 interacting protein HRK 31305 12.45 6.08E−05
Interleukin 11 (IL11) IL11 14082 2.96 0.0031661
Interleukin 13 receptor, alpha 2 (IL13RA2) IL13RA2 10906 22.09 0.0040849
Interleukin 18 receptor 1 (IL18R1) IL18R1 11707 7.51 0.0006791
Interleukin-6 receptor beta chain IL6ST 29182 2.05 0.0036609
Interleukin 8 (IL8) IL8 6975 6.55 0.0006952
NFKB inhibitor epsilon NFKBIE 34721 2.04 0.0030544
NFKB inhibitor-like 1 (NFKBIL1) NFKBIL1 12738 2.44 0.0014225
Suppressor of cytokine signaling 2 (SOCS2) SOCS2 37662 2.31 0.0018985
TEK tyrosine kinase, endothelial (TEK) TEK 7294 13.32 6.97E−05
Transferrin (TF) TF 2594 6.77 0.0023108
Toll-like receptor 3 (TLR3) TLR3 13279 3.42 0.001027
Toll-like receptor 4 (TLR4), transcript variant 1 TLR4 1711 4.62 0.0007938
Tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) TNFAIP3 2743 2.31 0.002519
Tumor necrosis factor receptor superfamily, member 11a (TNFRSF11a) TNFRSF11A 38575 3.73 0.0004463
Tumor necrosis factor receptor superfamily, member 21 (TNFRSF21) TNFRSF21 32413 2.47 0.0011732
Tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B) TNFSF13B 18553 1.95 0.0048793
Zinc finger protein 10 (ZNF10) ZNF10 13608 5.19 0.0001083
Zinc finger protein 528 (ZNF528) ZNF528 35665 11.77 1.03E−05
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expression of TRAIL-R2/DR5 (due to increased transcription and
protein trafficking) that was relatively similar in both ρ+ and ρ0 cells
24 h after treatment (Fig. 5E).
Furthermore, 24 h after irradiation protein levels of the NF-κB/
STAT3-dependent Survivin with anti-apoptotic activity were
upregulated only in ρ+ cells but not in ρ0 cells (Fig. 5B). In
contrast, basal levels of anti-apoptotic XIAP were substantially
downregulated in irradiated ρ+ cells, but were low and stable in ρ0
cells; c-FLIP (an inhibitor of caspase-8) levels were also substan-
tially decreased in ρ+ cells and were non-detectable in ρ0 cells 24
after irradiation (Fig. 5B). Only modest changes in Bcl-xL protein
levels were detected in irradiated HSF (Fig. 5B). Furthermore, basal
protein levels of Smac (DIABLO), a critical regulator of the
mitochondrial apoptotic pathway, and BAX, a pro-apoptotic
executor of the mitochondrial pathway, were notably decreased
in ρ0 cells compared to ρ+ cells. Smac levels were additionally
decreased after irradiation of normal fibroblasts (Fig. 5B).
Taken together, these results demonstrated relatively similar
changes in several signaling pathways induced by α-irradiation in
both ρ0 and ρ+ cells, while notable changes in basal and inducible
NF-κB and STAT activation, as well as in expression levels of their
target anti-apoptotic proteins (such as PTGS2/COX2, Survivin,
XIAP and cFLIP-L) suggested their role for a differential sensitiza-
tion of ρ0 versus ρ+ cells to death ligand-induced apoptosis. On the
other hand, down-regulated levels of pro-apoptotic regulators,
BAX and Smac, potentially could decrease levels of the mitochon-
dria-mediated apoptosis in ρ0 cells.
Cell cycle change and levels of cell death in normal and mtDNA-
depleted human fibroblasts after stress treatment
Our next aim was to investigate general effects of deficiency of
mitochondrial function on cell cycle and cell survival after
α-irradiation, including the regulation of both the mitochondrial
and the death receptor-mediated apoptotic pathways. Exposure to
ionizing radiation (0.5 Gy, α-particles) induced pronounced G2/M
arrest in HSF (Fig. 6A). This effect was substantially increased in ρ0
cells (a ratio of cell populations at G2/M versus G1 phase increased
from 0.7 to 2.1), probably based on numerous changes in the cell-
cycle regulatory proteins, such as p21-Cip1 (encoding by CDKN1A)
(Figs. 4A and 6B) and E2F3 transcription factor (encoding by E2F3),
which showed increased basal expression in mtDNA-depleted
Fig. 3 – Hierarchical clustering of gene expression after alpha irradiation of HSF ρ0 compared with HSF ρ+. A. HSF gene expression
responses at 4 h after irradiationwith 0.5 Gy alpha-particles; the heatmap of differentially expressed 265 genes wasmade using BRB
tools (http://linus.nci.nih.gov/BRB-ArrayTools.html). The inset displays a subset of the differentially expressed genes showing
MMP12 and PTGS2 gene expression. The scale bar indicates induced (red) and repressed (green) expression ratios. B. Gene ontology
analysis using PANTHER biological processes comparing HSF ρ0 to ρ+ gene expression response after irradiation with 0.5 Gy
α-particles. Functionally enriched categories are shown, p-values indicate statistical significance, p-value cut off 0.05 and NS is not
significant. C. Expression levels of selected genes in HSF ρ0 compared with HSF ρ+ 4 h after irradiation.
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cells (Table 2). No notable apoptosis was detected 24–48 h after
exposure of skin fibroblasts to α-radiation (0.5 Gy) (Fig. 6A).
Clonogenic survival assay demonstrated modest decrease in
survival of ρ0 cells compared to ρ+ cells reflecting slow death of
irradiated cells using non-apoptotic mechanisms 12 days after
irradiation (Fig. 6B).
On the other hand, changes in levels of Smac (DIABLO) and BAX
(Fig. 5B) could differentially sensitize mitDNA-deficient HSF and
normal HSF to apoptosis via the mitochondrial pathway. Indeed, a
combination of α-irradiation (0.5 Gy) and LY294002 (a PI3K–AKT
inhibitor) or sodium arsenite and LY294002 induced cell death that
could be substantially reduced by LEHD [N-acetyl-Leu-Glu-His-Asp-
Fig. 4 – Validation of differential gene expression in mtDNA-depleted human skin fibroblasts, (HSF ρ0), and their parental cells (HSF ρ+)
afterα-irradiationusingqRT-PCR. A. Heatmapof gene expression levels in the lowdensity array panel. Gene expressionwasdeterminedby
quantitative real time PCR (qRT-PCR). 33 genes were analyzed across the time course of 0.5, 1, 4 and 24 h in non-treated and α-irradiated
(0.5 Gy) cells. Heatmap for up-regulated and down-regulated genes was generated using BRB Array-Tools software. B. Relative gene
expressionchanges in IL6, IL8,PTGS2/COX2andTNFRSF1 inHSF in the timecourse.GeneexpressionwasdeterminedqRT-PCR.Points are the
mean of three independent replicates. C. Relative increase in IL6 secretion in ρ+ and ρ0 HSF 48 h after exposure to ionizing irradiation
(0.5 Gy).
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CHO (aldehyde)], a caspase-9 inhibitor, but less efficiently by IETD [N-
acetyl-Ile-Glu-Thr-Asp-CHO (aldehyde)], a caspase-8 inhibitor in
normal HSF (Fig. 6D), indicating that caspase-9-dependentmitochon-
drial pathway was involved in the execution of cell death following
these treatments. As expected, caspase-9-dependent apoptotic path-
way was substantially downregulated in ρ0 cells (Fig. 6D).
Surface receptor levels and death-ligand induced apoptosis
in normal and mtDNA-depleted human fibroblasts
As we already demonstrated, both ρ0 and ρ+ HSF exhibited TRAIL-
R2/DR5 surface expression at the similar levels, while surface
TRAIL-R1/DR4 was not detectable (Figs. 5E and 7A). TRAIL alone
Fig. 5 – Activation of the main signaling pathways and levels of target proteins after α-irradiation of HSF. A, B. Western blot analysis
of indicated proteins 4 h and 24 h after α-irradiation (0.5 Gy) of ρ+ and ρ0 HSF. C. NF-κB-dependent luciferase reporter activity
(2xNF-κB-Luc) was determined in transiently transfected ρ+ and ρ0 HSF before and 8 h after α-irradiation (0.5 Gy) or 8 h after TNFα
(20 ng/ml) treatment. D. STAT-dependent luciferase reporter activity (3xSTAT-Luc) was determined in transiently transfected ρ+
and ρ0 HSF before and 8 h after α-irradiation (0.5 Gy) or 8 h after IL6 (10 ng/ml) treatment. Error bars represent mean±S.D.
(Student's t test, p<0.05). E. Surface expression of TRAIL-R2/DR5 in HSF before and 24 h after α-irradiation was determined using
immunostaining and FACS analysis.
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was only amodest inducer of apoptosis in HSF. However, ρ0 and ρ+
HSF demonstrated different apoptotic response after treatment
with TRAIL in the presence of cycloheximide (CHX), an inhibitor of
protein synthesis and a classical accelerator of Fas-, TNFR- and
TRAIL-R-mediated apoptosis. Surprisingly, TRAIL+CHX induced
apoptotic levels were substantially higher in ρ0 cells compared to
ρ+ cells (Fig. 7B).
The basal levels of surface FAS and IL6Rα, both receptor
proteins are known as NF-κB transcriptional targets, were
decreased in ρ0 cells. Nerve growth factor receptor (NGFR1-p75/
TNFRSF16) surface expression was actually induced in mtDNA-
depleted HSF (Fig. 7A), although a role for such change was still
not established. Only modest alteration of FasL+CHX induced
apoptosis was observed in mtDNA-depleted HSF, compared to
control cells (Fig. 7B), probably due to the simultaneous decrease
in Fas surface levels and the NF-κB-dependent anti-apoptotic
protection in ρ0 cells. TNFα and CHX induced only marginal levels
of apoptosis in HSF. NGF alone or in concert with CHX did not
initiate pronounced apoptosis in HSF (Fig.7B).
An additional analysis of TRAIL+CHX induced apoptosis
demonstrated dose-dependent effects of TRAIL with substantially
increased levels of apoptosis in ρ0 cells (Fig. 8A). Pretreatment
Fig. 6 – Cell cycle and apoptotic analysis of mtDNA-depleted human skin fibroblasts (HSF ρ0) and their parental cells (HSF ρ+). A. Cell
cycle analysis of ρ+ and ρ0 HSF after α-irradiation (0.5 Gy) was performed using PI staining of DNA and FACS analysis. B. Clonogenic
survival fraction (SF) of control and treated cells 12 days after irradiation. C.Western blot analysis of indicated proteins 24 h after α-
irradiation (0.5 Gy) of ρ+ and ρ0 HSF. D. Apoptosis was induced by α-irradiation (0.5 Gy) alone or in combination with LY294002
(50 μM), sodium arsenite (As, 4 μM) alone or in combination with LY294002 (50 μM), in the presence or the absence of caspase
inhibitors, IETD or LEHD (50 μM), in ρ+ and ρ0 HSF.
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with α-radiation (0.5 Gy) further increased levels of TRAIL and
CHX induced apoptosis in both ρ0 and ρ+ cells (Fig. 8B), due to
radiation-induced upregulation of surface expression of TRAIL-R2/
DR5 [5], whichwas observed in both ρ0 and ρ+ cells (Fig. 5E), and a
partial down-regulation of cell anti-apoptotic functions. TRAIL+
CHX induced apoptosis was significantly blocked by IETD
(caspase-8 inhibitor), but less efficiently by LEHD (caspase-9
inhibitor) (Fig. 8B).
Fig. 7 – Surface expression of receptors and death ligand/receptor-induced apoptosis in HSF. A. Surface expression of TRAIL-R2/DR5,
TRAIL-R1/DR4, FAS, TNFR1, NGFR1 and IL6Rαwas determined using immunostaining with the corresponding PE-labeled mAbs and
the subsequent FACS analysis of ρ+ and ρ0 HSF. Medium fluorescent intensity (MFI) is indicated in brackets. B. Induction of apoptosis
by ligands, FasL (25 ng/ml), TNFα (20 ng/ml) and NGF (50 ng/ml) in the presence CHX (1 μg/ml).
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TRAIL+CHX treatment after 6 h induced relatively similar
cleavage of procaspase-8 and procaspase-3 in HSF, which was
somewhat more pronounced in ρ0 cells. The basal anti-apoptotic
activity of cFLIP-L (an inhibitor of caspase-8), XIAP and Survivin
(inhibitors of the executive caspases) was finally involved in
modulation of caspase-3 enzymatic activity, resulting in its
increase in ρ0 cells that was well detected using caspase-3 classical
target PARP (Fig. 8C). Furthermore, direct determination of
enzymatic activities of caspase-8, caspase-9 and caspase-3 in
total cell lysates demonstrated upregulated levels of caspase-
8 and, especially caspase-3 activity in ρ0 cells compared to ρ+ cells
6 h after treatment of cells with TRAIL+CHX. Caspase-9 activity
was increased in ρ+ but not in ρ0 cells (Fig. 8D).
Taken together, these results demonstrated that depletion of
mtDNA (accompanied by inhibition of mitochondrial function)
caused a substantial downregulation of activation of the
Fig. 8 – TRAIL and CHX induced apoptosis in HSF. A. Dose-dependent response of ρ+ and ρ0 HSF to TRAIL (10–100 ng/ml) in the
presence of cycloheximide (CHX, 1 μg/ml). Apoptotic levels (% cells in pre-G1/G0) were determined 48 h after treatment using PI
staining and FACS analysis. Error bars representmean±S.D. (Student's t test, p<0.05). B. Apoptosis induced by TRAIL (50 ng/ml) and
CHX (1 μg/ml) in the presence or the absence of IETD or LEHD (50 μM) in ρ+ and ρ0 HSF. An additional effect of α-irradiation (IR at
0.5 Gy) on (TRAIL+CHX)-induced apoptosis was also determined. Apoptotic levels (% cells in pre-G1/G0)were determined 48 h after
treatment using PI staining and FACS analysis. Error bars representmean±S.D. (Student's t test, p<0.05). C.Western blot analysis of
caspase-8-dependent pathway following TRAIL+CHX treatment of HSF. Decreased levels of procaspase-8 (determined with mAb to
p55) reflect its cleavage and activation. The subsequent activation of caspase-3 results in PARP cleavage that was more advanced in
ρ0 HSF. D. Relative specific activity of caspase-8, caspase-9 and caspase-3 in total cell extracts of ρ+ and ρ0 HSF 6 h after TRAIL+CHX
treatment.
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mitochondrial apoptotic pathway (Fig. 6D). However, this deple-
tion simultaneously upregulated levels of activation of the
exogenous TRAIL-Receptor-mediated pathway (Fig. 8), probably
due to a partial suppression of anti-apoptotic functions in ρ0 cells.
Expression levels of many NF-κB-dependent target genes were
downregulated in mtDNA-depleted cells. The initiation of cell
signaling cascades that activate IKK–NF-κB could be a result of several
types of ligand/receptor interactions. TNFα/TNFR1 interaction is
known to be one of the major inducers of the IKK–NF-κB pathway
[41]. Decreased TNF-R1 surface expression could further down-
regulate NF-κB-driven transcription induced by exogenous TNFα in
mtDNA-depleted cells (Fig. 7A). Based onvery low levels of expression
determined by qRT-PCR and ELISA, endogenous TNFα was not
probably the main inducer of NF-κB in skin fibroblasts, suggesting
Fig. 9 – Modulation of TRAIL-induced apoptosis in HSF using inhibitory mAbs and low molecular inhibitors of cell signaling
pathways. A, B. Effects of suppression of IKKβ–NF-κB by BMS-345541 (10 μM) and JAK2–STAT3 by AG490 (50 μM) on 2xNF-κB-Luc
and 3xSTAT3-Luc reporter activities, respectively, in transiently transfected HSF. C. Effects of suppression of IKKβ–NF-κB by
BMS-345541 (10 μM) and JAK2–STAT3 by AG490 (50 μM) on TRAIL-induced apoptosis. Apoptotic levels (% cells in pre-G1/G0) were
determined 48 h after treatment using PI staining and FACS analysis. Error bars represent mean±S.D. (Student's t test, p<0.05).
D. Effect of IKKβ–NF-κB inhibitor, BMS-345541 (10 μM), on relative increase in IL6 secretion in ρ+ and ρ0 HSF 48 h after exposure to
ionizing irradiation. E. Effects of blockage of IL6- or IL8-dependent signalingwith anti-IL6mAb (5 μg/ml) or anti-IL8mAb (5 μg/ml),
respectively, added into the cell media on TRAIL-induced apoptosis in ρ+ and ρ0 HSF. Cells were additionally pretreated with 0.5 Gy
α-irradiation (the right panel). Error bars represent mean±S.D. (Student's t test, p<0.05).
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that a different ligand–receptor interaction (such as IL1β/IL1R, IL33/
ST2, FasL/FAS, TRAIL/DR5)might initiate the NF-κB signaling pathway
inHSF via autocrine/paracrinemechanisms. Aswealreadymentioned,
IL1β secretion by normal HSF increased almost 2-fold 24 h after
irradiation, while ρ0 cells did not demonstrate upregulation of IL1β
secretion.
Based on numerous investigations of a role for NF-κB in both
cell survival and cell death regulatory pathways [42], we further
elucidated the significance of this transcription factor for regula-
tion of TRAIL-mediated apoptosis in HSF, suggesting that pharma-
cological inhibition of NF-κB activity in ρ+ cells would increase
TRAIL-mediated apoptosis in these cells close to levels observed in
mtDNA-depleted cells (with decreased NF-κB activity).
Suppression of IKKβ-NF-κB and JAK2–STAT3 activities and
upregulation of TRAIL-induced apoptosis in HSF
Both IKKβ-NF-κB and JAK2–STAT3 pathways are involved in the
regulation of cell proliferation, cell survival and death. Several
cytokines (including IL6), which are NF-κB transcriptional targets,
further activate the JAK2–STAT3 pathway by paracrine/autocrine
mechanisms [43]. To provide evidence that downregulation of
critical NF-κB gene targets was responsible for upregulation of
TRAIL-induced apoptosis in ρ0 cells, we suppressed activity of the
IKK–NF-κB pathway by IKKβ inhibitor BMS-345541 (10 μM) that
resulted in the general suppression of NF-κB-driven transcription
in HSF (Fig. 9A). Furthermore, we used AG490 (50 μM), a JAK2–
STAT3 inhibitor, to evaluate the effect of suppression of the STAT3
signaling pathway in regulation of TRAIL-induced apoptosis
(Fig. 9B). Both IKKβ–NF-κB inhibitor and JAK2–STAT3 inhibitor
substantially increased levels of TRAIL and CHX induced apoptosis
of ρ+ HSF (Fig. 9C). Hence, active NF-κB and STAT3 caused
suppression of TRAIL+CHX induced apoptosis in ρ+ cells, which
almost achieved the levels observed in ρ0 cells when NF-κB was
inhibited in ρ+ cells.
HSF actively express and produce IL6. Radiation induced activation
of NF-κB pathway upregulated expression of IL6 gene followed by
increased IL6 secretion into the media. This was less pronounced in
mtDNA-depleted cells; furthermore, IKK–NF-κB inhibitor substantially
blocked IL6 secretion in normal HSF before and after irradiation
(Fig. 9D). Inhibitorymonoclonal antibodies (mAbs) against IL6 and IL8
were added to the cell media blocking autocrine and paracrine signal
transmission in HSF that was potentially linked with the downstream
activation of STAT3. Anti-IL6, but not anti-IL8 mAb increased levels of
TRAIL and CHX induced apoptosis in both ρ+ and ρ0 HSF, especially
after α-irradiation, further demonstrating protective effects of IL6
against TRAIL-mediated apoptosis (Fig. 9E). However, IL6-dependent
signaling pathway with the downstream activation of STAT3 was not
the only critical anti-apoptotic regulator in HSF, since suppression of
IL6 signalingpathwayby inhibitorymAbdidnot result in similar levels
of TRAIL+CHX induced apoptosis for both ρ+ and ρ0 HSF (Fig. 9E).
A role of IL33, an alternative inducer of the NF-κB signaling
pathway was recently described for signal transduction in HSF.
Accordingly, anti-IL33 mAb also additionally increased TRAIL-
mediated apoptosis of HSF [44]. Taken together, our data
confirmed a role of the IKKβ–NF-κB and JAK2–STAT3 pathways
in protection from TRAIL+CHX induced apoptosis in HSF and
indicated that a partial suppression of these pathways in mtDNA-
depleted cells might be responsible for upregulation of TRAIL-
induced apoptosis.
Regulation of TRAIL-induced apoptosis in mtDNA-depleted
SAEC
To further confirm upregulation of TRAIL and CHX induced apoptosis
in mtDNA-depleted cells, we used the second system of mtDNA-
depleted cells that was established from human small airway
epithelial cells (SAEC) immortalized by hTERT (Suppl. Fig. 1A), as a
result of a prolonged treatmentof SAECbyethidiumbromide. Creation
of this cell system was substantially more difficult task compared to
HSF, due to probably a recently described phenomenon of strong
positive effect of telomerase activity onnormalmitochondrial function
[45]. As expected, mtDNA-depleted SAEC had suppressed cyto-
chrome-c oxidase activity (Suppl. Fig. 1B), strongly downregulated
mitochondrial membrane potential (Suppl. Fig. 1B) and profoundly
decreased levels of oxygen consumption (Suppl. Fig. 1C). Both ρ0 cells
and the parental ρ+ SAEC demonstrated negligible levels of DR4 and
intermediate surface levels of DR5 (Suppl. Fig. 2A). Similarly with the
HSF system, ρ0 SAEC showed decreased apoptosis levels induced
through the mitochondrial pathway with a combination of sodium
arsenite and LY294002 (Suppl. Fig. 2B). However, upregulation of
levels of TRAIL+CHX induced apoptosis was observed in ρ0 SAEC
(Suppl. Fig. 2B). Pretreatment with IKKβ inhibitor, BMS-345541
(10 μM), further increased levels of TRAIL+CHX induced apoptosis
in ρ+ SAEC that almost achieved levels in ρ0 SAEC (Suppl. Fig. 2C). An
inhibitory antibody against IL6 also increased levels of TRAIL and CHX
induced apoptosis in ρ+ SAEC (Suppl. Fig. 2D). Collectively, these data
confirmed a protective role of IKKβ–NF-κB, as well as NF-κB
dependent IL6 signaling against TRAIL and CHX induced apoptosis
and demonstrated a partial loss of the NF-κB-dependent protective
function in mtDNA-depleted SAEC.
Discussion
The delivery of energy by oxidative phosphorylation [46] and
execution of cell death by apoptosis [47] are crucial functions of
mitochondria, the disturbance of which could be involved in the
initiation and progression of human pathology. Comprehensive
gene analysis of mtDNA-depleted cells that was performed in the
present study convincingly demonstrated a substantial contribu-
tion of mitochondria in the regulation of expression of pro-
inflammatory signature genes, IL6, ΙL17Β, ΙL18, ΙL19, ΙL28Β, IL1R1,
IL21R and IL31RA, which were decreased after mitochondrial DNA
depletion. A recent publication of Zhou et al. [48] further
confirmed a direct connection between mitochondrial function
and the inflammasome activation.
The proper and efficient function of the mitochondrial death
pathway,which is activated by different types of stress, requires high
levels of ATP [9]. The common strategy of cancer genomes during
cancer progression driven by Darwinian selection is to substitute
oxidative phosphorylation by oxidative glycolysis with strongly
decreased production of ATP [9,49]. This can be achieved by different
approaches, such as mitochondrial mutagenesis affecting key
enzymes of the oxidative phosphorylation or general mitochondrial
DNA depletion [50]. Alternatively, induction of HIF-1 expression that
stimulated key steps of glycolysis and inhibited the Krebs cycle
resulted in suppression of mitochondrial function [13,51]. Together
with upregulation of anti-apoptotic proteins of the Bcl2 family, the
inhibition of mitochondrial respiration results in suppression of the
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activity of the mitochondrial death pathway in most human
carcinomas, undoubtedly demonstrating the selective advantage of
cancer clones with suppressed mitochondrial function.
Consequently, one of the critical problems for cancer treatment
is whether alternative death receptor-mediated apoptotic path-
ways remain active or could be reactivated in cancer cells with
partially or almost completely suppressed mitochondrial function
and a deficiency of ATP. It is necessary to highlight that at normal
energy conditions in cells, the mitochondrial and the death-
receptor mediated pathway could tightly collaborate with addi-
tional amplification of effects for receptor-mediated apoptosis. It
takes place through the mitochondrial route based on caspase-
8 mediated processing of Bid followed by tBid, BAX, BAK and Bcl-2/
Bcl-xL interaction and mitochondrial outer membrane permeabi-
lization [2,8]. However, the suppression of the mitochondrial
pathway during cancer development does not automatically turn
off the death-receptor pathway. Paracrine and autocrine cytokine
and growth factor signaling that dramatically increases during
cancer progression could additionally increase survival functions in
cancer cells through blockage of the death receptor mediated
pathways based on the NF-κB and STAT3 signaling, which appears
to play the leading role for regulation of cancer cell proliferation
and survival [43].
To address the problem of activity of TRAIL-Receptor mediated
pathway for induction of apoptosis in the case of suppression of
mitochondrial functions, we used in the present study a well
established, but simplified model system of mtDNA-depleted ρ0
cells [14]. Multiple roles of NF-κB and STAT3 in the positive and the
negative regulation of apoptotic pathways have been a subject of
numerous investigations [52–54]. In general, IKK–NF-κB–IL6–
JAK2–STAT3 signaling pathway is involved in anti-apoptotic
protection of normal and cancer cells [55–57]. Mutual cross-talk
between ROS originating from mitochondria and NF-κB signaling
pathways has been established and elucidated during the last two
decades [52]. Based on a probable association between TRAIL-
mediated apoptosis, mitochondrial function, NF-κB and STAT3,
three main goals of the present study were: i) to determine how
suppression of mitochondrial function affects TRAIL/TRAIL-R-
mediated apoptosis; ii) to determine the role of changes in the
pattern of NF-κB- and STAT3-directed transcription for regulation
of apoptosis in mtDNA-depleted cells; iii) to determine effects of
suppression of NF-κB- and STAT3-dependent gene expression that
controls cell survival mechanisms in the parent ρ+ cells for
modeling of deficiency of mitochondrial function.
The results of our study demonstrated a substantial upregula-
tion of TRAIL and CHX induced apoptosis in mtDNA-depleted ρ0
cells, compared with parental ρ+ cells. Gene expression analysis
indicated that NF-κB-driven inflammatory signature genes (IL1β,
IL6, COX2, MMP3 and MMP12) exhibited decreased basal and
radiation-induced expression in mtDNA-depleted cells. Further-
more, expression of NF-κB target antioxidant gene SOD2 was not
upregulated in mtDNA-depleted cells 24 h after irradiation
(Fig. 4A). Several NF-κB target cytokine genes, including IL6,
further induced JAK2–STAT3 activation, providing a “vertical”
connection between NF-κB and STAT3 [43]. Direct protein–protein
interaction between NF-κB p65 and STAT3, demonstrated a
“horizontal” association between two master transcription factors
[58], which might additionally increase the complexity of
regulatorymechanisms of cell survival. Furthermore, IL6-mediated
signaling can activate NF-κB, establishing a positive feedback loop
involving NF-κB, specific microRNAs and STAT3 that maintain
inflammation and links inflammation to cell transformation [59].
Recent publications demonstrated a linkage of STAT3 expres-
sion with the mitochondrial respiration additionally confirming
serious changes in STAT3 activation in ρ0 cells [60,61]. Inhibition of
IKK–NF-κB and IL6–JAK2–STAT3 signaling pathways at different
points caused an increase in TRAIL-R-mediated apoptosis in ρ+
cells that could almost achieve the apoptotic levels observed in ρ0
cells. Taken together, these results provide additional evidence of
the critical role of NF-κB/STAT3-dependent gene expression for the
negative regulation of TRAIL/TRAIL-R-mediated apoptosis in the
parent HSF, which is partially lost in mtDNA-depleted cells.
The final goal of our study was to explore the possibility of
increasing the sensitivity of cancer cells to TRAIL/TRAIL-R-
mediated apoptosis in conditions of partial suppression of the
mitochondrial death pathway. We recently demonstrated for
several human melanoma cell lines dramatically increased
susceptibility to TRAIL by combined treatment of TRAIL with
IKKβ–NF-κB, JAK2–STAT3 inhibitors or with directly targeting
mitochondrial function using sodium arsenite [62]. Due to the
enormous genetic and epigenetic diversity of melanoma cells, such
an approach probably could not be universal; even if it works
successfully for many melanoma lines, characterized by average
levels of surface expression of TRAIL-R and basal activation of NF-
κB, as well as for neuroblastoma cell lines. Furthermore, recent
investigation demonstrated that a conditional knock-out of IKKb
inhibited melanoma development in mice [63] and there are
several clinical trials of cancer treatment by TRAIL in a combination
with inhibitors of NF-κB activation [12]. Many efficient inhibitors
of JAK2–STAT3 were created in recent years, some of which
demonstrated well pronounced anti-cancer effects [64]. Results of
the present study and recently published paper [62] suggest usage
of these inhibitors in combination with TRAIL for additional
upregulation of apoptosis in cancer cells. On the other hand,
widely used inhibition of the anti-apoptotic functions of the
members of the Bcl-2 family for upregulation of the mitochondrial
death pathway in cancer cells [11] appears to be a valuable
approach for treatment of cancer cells with relatively mild and
reversible suppression of mitochondrial function.
Global gene expression analysis of HSF performed in our study
demonstrated significant changes in gene expression of 2100
nuclear genes involving in the regulation of numerous cellular
functions after mitochondrial depletion. The main goal of the
present study was focused on the problem of upregulation of the
death receptor-mediated apoptosis in mtDNA-depleted cells in the
context of suppression of NF-κB and STAT3 activation and down-
regulation of expression of NF-κB- and STAT3 target genes with
anti-apoptotic activity, such as PTGS2/COX2, Survivin and XIAP.
However, our results of analysis of gene expression in mtDNA-
depleted cells can be extensively used in the future studies on the
fundamental role of mitochondria in the specific regulation of the
nuclear gene expression. An arising role of mitochondria in the
regulation of lifespan of the multicellular organisms [65] could be
directly linked with results obtained in the present study,
especially with regulation of nuclear pro-inflammatory gene
expression directed by mitochondrial function.
The important clinical problem tightly linked with mitochon-
drial function is radiation response of human fibroblasts and its
changes in mtDNA-depleted cells. We substantially extended our
previous observations [22,44], demonstrating multiple differential
1564 E X P E R I M E N T A L C E L L R E S E A R C H 3 1 7 ( 2 0 1 1 ) 1 5 4 8 – 1 5 6 6
Author's personal copy
changes in gene expression following α-irradiation in ρ0 cells
versus ρ+ cells. Interestingly, ionizing irradiation of normal HSF at
low doses induced gene expression of numerous cytokines, growth
factor and their receptors that were important for cell survival. In
contrast, expressions of the same genes were substantially down-
regulated in mtDNA-deficient HSF providing conditions for
upregulation of death-receptor-mediated apoptosis in these cells.
The results obtained in the present study could be a basis for the
future work linked with sensitization of cancer cells exhibiting
suppressed mitochondrial function to radiation treatment, espe-
cially in the presence of inhibitors of PI3K–AKT signaling pathway
or specific inhibitory mAbs for different cytokines with survival
functions.
Supplementary materials related to this article can be found
online at doi:10.1016/j.yexcr.2011.03.012.
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